Medications that should not be split
Pro Research Analysisby 
Searched over 200M research papers
Medications That Should Not Be Split: Key Risks and Considerations
Extended-Release, Enteric-Coated, and Special Formulations
Splitting extended-release or enteric-coated tablets is widely recognized as unsafe. These formulations are designed to release the drug slowly or protect it from stomach acid, and splitting them can lead to rapid drug release, reduced effectiveness, or increased side effects. This risk is consistently highlighted across multiple studies, which emphasize that extended-release, enteric-coated, and other modified-release tablets should never be split or crushed due to the potential for harmful dosing errors and loss of intended drug action 23456.
Capsules and Non-Scored Tablets
Capsules, especially those filled with powder, should not be split. Research shows that splitting capsules results in highly uneven doses, with the base of the capsule containing much more of the drug than the top. This can lead to patients receiving only a fraction of the intended dose or, conversely, too much, making capsule splitting an unreliable and potentially dangerous practice .
Similarly, unscored tablets are difficult to split accurately, often resulting in significant dose variation. Studies have found that splitting unscored tablets can lead to deviations of more than 15% or even 25% from the intended dose, which is particularly concerning for medications with narrow therapeutic windows 678.
Medications with Narrow Therapeutic Index
Medications that require precise dosing—such as those with a narrow therapeutic-toxic range—should not be split. Even small deviations in dose can lead to underdosing or toxicity. Research shows that splitting tablets often results in unequal halves, which can be especially dangerous for drugs where small changes in dose have significant clinical effects 8910.
Dose Uniformity and Patient Safety
Multiple studies have demonstrated that splitting tablets, whether by hand or with tools, often results in uneven doses and loss of tablet mass. This is true even for scored tablets, though the risk is higher for unscored ones. The lack of dose uniformity can compromise treatment efficacy and safety, especially in vulnerable populations such as older adults or those taking psychoactive medications 678910.
Patient Knowledge and Practice
Many patients are unaware of which medications can be safely split or crushed, and a significant number do so without consulting healthcare providers. This lack of knowledge increases the risk of medication errors. There is a clear need for better education and communication about which medications should not be split or crushed to prevent harm .
Conclusion
In summary, medications that should not be split include extended-release, enteric-coated, and other modified-release formulations, capsules, unscored tablets, and drugs with a narrow therapeutic index. Splitting these medications can lead to uneven dosing, reduced effectiveness, or increased risk of side effects and toxicity. Patients should always consult healthcare providers before splitting or crushing any medication to ensure safety and effectiveness 12345678+2 MORE.
Sources and full results
Most relevant research papers on this topic